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Abstract Language and learning disorders such as reading
disability and language impairment are recognized to be
subject to substantial genetic influences, but few causal
mutations have been identified in the coding regions of
candidate genes. Association analyses of single nucleotide
polymorphisms have suggested the involvement of regula-
tory regions of these genes, and a few mutations affecting
gene expression levels have been identified, indicating that
the quantity rather than the quality of the gene product may
be most relevant for these disorders. In addition, several of
the candidate genes appear to be involved in neuronal
migration, confirming the importance of early developmen-
tal processes. Accordingly, alterations in epigenetic pro-
cesses such as DNA methylation and histone modification
are likely to be important in the causes of language and
learning disorders based on their functions in gene
regulation. Epigenetic processes direct the differentiation
of cells in early development when neurological pathways
are set down, and mutations in genes involved in epigenetic
regulation are known to cause cognitive disorders in
humans. Epigenetic processes also regulate the changes in
gene expression in response to learning, and alterations in
histone modification are associated with learning and
memory deficits in animals. Genetic defects in histone
m o d i f i c a t i o nh a v eb e e nr e v e r s e di na n i m a l st h r o u g h
therapeutic interventions resulting in rescue of these
deficits, making it particularly important to investigate their
potential contribution to learning disorders in humans.
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Introduction
Despite the complexity of language and learning disorders,
individual genes are being defined which appear to
influence the development of abilities that are necessary
in speech, language, and reading. Most of the identified
candidate genes involve reading disability, and although the
evidence supporting some of these genes is still somewhat
tenuous due to small sample sizes and limited replication,
most are known to be involved in early development,
particularly neuronal migration (Galaburda 2005; Gabel et
al. 2010; Poelmans et al. 2011). As will be discussed below,
most of these candidate genes have been associated with
several learning and language phenotypes, suggesting that
they facilitate learning processes which are basic to learning
reading and language. Similar pleiotropic effects are seen
for several genes that primarily affect autism or language
but have also shown effects on reading, including
CNTNAP2 and ATP2C2 (Vernes et al. 2008; Newbury et
al. 2011). However, despite replicated evidence for associ-
ation of single nucleotide polymorphisms within and
around the genes, very few coding mutations have been
reported to account for their influence on these disorders.
This has led to the hypothesis that mutations affecting
reading and related disorders are likely to be in regulatory
regions, controlling the quantity rather than quality of the
gene product (Bates et al. 2011). Alterations of gene
expression can be caused by mutations in gene promoters
and enhancers located near the gene, but mutations in genes
that mediate epigenetic controls of gene expression have
been found that affect developmental learning disorders.
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Regulatory regions of genes influencing language
and learning disorders
Of all of the genes that have been proposed as candidates for
reading disability and language impairment, six genes have
been well characterized with respect to their influence on
readingandlanguagedisorders,theregions withinandaround
the genes that appear to contain causal mutations, and the
effects of the putative mutations or risk alleles on gene
transcription: DYX1C1, DCDC2, KIAA0319, ROBO1,a n d
the co-regulated genes MRPL1 and C2ORF3.
DYX1C1 The 15q21 region was identified as a candidate
region for a gene or genes influencing reading disability (RD)
through linkage studies (Fulker et al. 1991;G r i g o r e n k oe ta l .
1997), defining the DYX1 (DYsleXia-1st reported) locus.
The DYX1C1 (DYX1-Candidate 1) gene was specifically
targeted after a translocation t(2;15) (q11;q21) disrupting the
previously uncharacterized gene was observed in a family
with RD (Taipale et al. 2003). Since then, the DYX1C1
protein has been found to contain estrogen-receptor-binding
sites (Massinen et al. 2009) and knockdown of the gene in
embryonic rat brain produces delays in neuronal migration
(Wang et al. 2006).
Sequence analysis of the DYX1C1 coding regions identi-
fied a missense mutation in some RD families: rs57809907,
1249G>T, which results in Glu417X and truncates the
protein by four amino acids (Taipale et al. 2003), but this
variant has not been consistently associated with reading
disability in other studies (Scerri et al. 2004;W i g ge ta l .
2004;M a r i n oe ta l .2005;M e n ge ta l .2005a; Dahdouh et al.
2009; Bates et al. 2010). Another missense mutation,
rs17819126 (271G>A, Val91Ile) has been associated with
reading ability (Bates et al. 2010), but analyses of putative
effect on protein function by the SIFT (Ng and Henikoff
2003) and PolyPhen (Adzhubei et al. 2010)a l g o r i t h m s
indicate that this should be a benign change for the protein
(Ensembl release 63: www.ensembl.org). Since studies have
found association of RD with other SNPs within the gene, it
seems likely that mutations affecting RD are in the regulatory
ratherthancodingregions.A possible candidateisthe –3G>A
SNP rs3743205 in the 5′ untranslated region (UTR). In the
original report by Taipale et al. (2005), the A allele was
associated with RD, but subsequent reports found association
with the common G allele (Scerri et al. 2004;W i g ge ta l .
2004; Dahdouh et al. 2009). Interestingly, a study of RD in
Chinese children also found strong association with the G
allele (Lim et al. 2011). Studies of transcription factor
binding in the promoter region have shown that the A allele
shows decreased binding to a repressive transcription factor,
resulting in increased DYX1C1 expression (Tapia-Paez et al.
2008), leading Lim et al. to hypothesize that the A allele is
actually protective compared to the downregulating G allele,
andthatinstanceswheretheAalleleappearedtobeassociated
with RD could be secondary to linkage disequilibrium with a
second causal variant nearby. Two other SNPs, rs12899331
and rs16787, in the promoter region were also found to be
involved in transcription factor binding (Tapia-Paez et al.
2008), but these were not found to be associated with RD in
later studies (Dahdouh et al. 2009). Thus, further studies are
needed to define the role of particular regulatory regions of
DYX1C1 in the cause of RD.
There is also evidence for pleiotropic effects of
DYX1C1 on short-term memory and mental calculation, a
mathematics measure (Marino et al. 2011a). Linkage to the
DYX1C1 region was found with speech sound disorder
phenotypes (SSD) in one study (Smith et al. 2005) but not
in a subsequent study (Stein et al. 2006), which located the
SSD region more centromerically. Further studies are
needed to determine whether the linkage signal for SSD
was actually related to DYX1C1.
DCDC2 Initial linkage and association analysis defined the
DYX2 locus on chromosome 6p22 (Grigorenko et al. 1997;
Cardon et al. 1994; Cardon et al. 1995; Fisher et al. 1999;
Gayan et al. 1999; Kaplan et al. 2002; Deffenbacher et al.
2004), and several subsequent studies have reported
associations with the DCDC2 (doublecortin-2) gene within
the region (Newbury et al. 2011; Meng et al. 2005b;
Schumacher et al. 2006; Scerri et al. 2011). The structure of
the gene is analogous to the X-linked DCX gene which is
known to be involved in microtubular structure and
influences neuronal migration. Mutation of the DCX gene
produces lissencephaly in males and cortical abnormalities in
females (des Portes et al. 1998; Sossey-Alaoui et al. 1998);
accordingly, knockdown of DCDC2 produces delays in
neuronal migration in embryonic rat brain (Meng et al.
2005b).
Sequence analysis of coding regions of DCDC2 in RD
families has not identified causal mutations; however,
association of RD was reported with a deletion in intron
2, termed BV677278, which appeared to contain transcrip-
tion factor binding sites (Meng et al. 2005b). One study
failed to replicate this association (Ludwig et al. 2008), but
other studies have replicated it (Brkanac et al. 2007; Harold
et al. 2006; Wilcke et al. 2009; Marino et al. 2011b),
although the statistical significances in some of these
studies were weak. Still, the importance of this region in
gene regulation has been demonstrated by in vitro studies
showing that sequences in the region act as enhancers for
DCDC2 expression (Meng et al. 2011). Furthermore, these
differences in gene expression may have a measurable
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variants have been associated with differences in gray
matter volume in unselected individuals (Meda et al. 2008),
so this deletion appears to be an example of a mutation in a
regulatory region that affects RD.
In addition to influencing RD, SNPs in DCDC2 have been
associated with both hyperactive and inattentive forms of
ADHD, indicating that this gene can affect both disorders
(Couto et al. 2009). More recently, evidence has been
presented that DCDC2 contributes to the risk for autism in
families with both dyslexia and autism (Cuccaro et al. 2011).
KIAA0319 DCDC2 and KIAA0319 coding regions are
separated by only 160 kb and were both included in the
candidate region defined by linkage and association
analyses that identified the DYX2 locus. Association of
KIAA0319 with RD phenotypes as well as reading in the
normal range has been supported by numerous studies
(Newbury et al. 2011; Dennis et al. 2009; Scerri et al. 2011;
Harold et al. 2006; Cope et al. 2005; Paracchini et al. 2006;
Luciano et al. 2007; Paracchini et al. 2008). Although the
function of the gene is not clear, knockdown of expression
in embryonic rat brain results in delayed neuronal migration
(Paracchini et al. 2006), similar to the knockdowns of
DYX1C1 and DCDC2 noted above.
The SNPs showing association with RD tend to be located
in the 5′ UTR, the first untranslated exon, and the first intron
(Elbert et al. 2011), suggesting regulatory functions. Expres-
sion of the allele containing the RD-associated SNP
haplotype in this region of KIAA0319 was shown to be
decreased in cell lines from individuals with RD (Paracchini
et al. 2006). Moreover, one associated SNP, rs9461045, has
been shown to have a regulatory function. Reporter assays
showed that the risk allele, which was hypothesized to create
a binding site for the repressor OCT-1, resulted in decreased
expression of KIAA0319 in vitro, and knockdown of OCT-1
restored expression (Dennis et al. 2009).
In recognition of the likely influence of epigenetic
mechanisms on KIAA0319 expression in the etiology of
RD, regions of acetylated histones were mapped in and
around the gene in a neuroblastoma cell line to identify
promoter regions (Couto et al. 2010). A 2.7-kb acetylated
region was found spanning the 5′ UTR, first exon and first
intron of KIAA0319 which corresponded to the location of
five SNPs that had been associated with RD phenotypes in
other studies. In addition, SNPs within or very near the
acetylated region have been associated with language
impairment phenotypes (Newbury et al. 2011; Rice et al.
2009) and linkage to the DCDC2/KIAA0319 region has
been reported for SSD (Smith et al. 2005). Studies in an
unselected population did not show effects on language in
the normal range, suggesting that this gene has more of an
effect on language impairment (Scerri et al. 2011).
ROBO1 Linkage analysis of a large family localized RD to
a region on chromosome 3 (3p12-q13) which was desig-
nated DYX5 (Nopola-Hemmi et al. 2001). A translocation
within this region, t(3;8)(p12;q11), was found in an
individual with RD and it was determined that this
disrupted the ROBO1 gene (Hannula-Jouppi et al. 2005),
making it a candidate for RD. This gene is the human
homologue of the roundabout gene in Drosophila and mice
and is known to affect axonal guidance through the midline
of the CNS and spinal cord. The coding regions of the
ROBO1 gene were sequenced in the original DYX5 family,
but no causal mutations were found. Association was found
with a haplotype of SNPs in the gene in this family, and
transcription of the allele containing the risk haplotype was
decreased in lymphoblasts from individuals with RD. The
individuals SNPs were not felt to have a regulatory function
since they were also noted in unaffected individuals,
pointing to an unknown regulatory mutation in the
individuals with the risk haplotype. Although subsequent
studies have not replicated the association of ROBO1 SNPs
with RD, linkage has been found with SSD (Stein and
Schick 2004) and SNP association has been found with
phonological buffer deficits in an unselected population
(Bates et al. 2011) indicating that the gene’s primary effects
could be on language abilities related to RD.
MRPL19 and C2ORF3 The designation of these two genes
as candidates in influencing RD rests on the assumption that
thecausalmutationisinaregulatoryregionthatisabout34kb
from the genes. The 2p16–p12 region was first highlighted by
a genome-wide microsatellite linkage study in an extended
family (Fagerheim et al. 1999), and subsequent linkage
studies replicated these results across the region (Petryshen
et al. 2002; Fisher et al. 2002; Francks et al. 2002; Kaminen
et al. 2003). SNP association studies focused on the 2p12
region, with results indicating a region that did not contain
recognizable genes (Peyrard-Janvid et al. 2004;A n t h o n ie t
al. 2007). The transcription products of three nearby genes,
FLJ13391, MRPL19, and C2ORF3, were examined to
determine if the risk haplotype of SNPs in that region had
an effect on gene expression. There was no effect on the
transcription of FLJ13391, but transcripts of one allele from
MRLP19 and C2ORF3 were decreased in individuals who
carried the risk haplotypes in the adjacent region (as
determined by heterozygous SNPs within the coding regions
of the two genes). This suggested that an unknown mutation
in the region of SNP association has an effect on gene
expression of both genes. The MRPL19 protein is a
component of the mitochondrial ribosome, but the function
of the C2ORF3 gene is unknown.
Overall, there is substantial evidence for involvement of
mutations in regulatory regions of the primary candidate
genes influencing RD, and several of these genes also affect
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tion of epigenetic mechanisms of gene regulation is likely
to be profitable, including elements that may be quite
distant from the genes they affect, or factors that regulate
more than one gene.
Mechanisms of epigenetic gene regulation
The term “epigenetics” refers to the controls of gene
expression that are maintained through somatic cell division
(and occasionally in germline cells) but do not involve
change in the DNA code itself. Stable epigenetic controls
are applied and subsequently maintained in cell lineages
during differentiation and cell proliferation, and reversible
epigenetic changes in gene expression can occur in
differentiated cells in response to external signals (Jaenisch
and Bird 2003; Ptashne 2007; Day and Sweatt 2011). The
two major methods of epigenetic regulation involve
changes in methylation of cytosines in regulatory regions
of DNA or modification of histone proteins, primarily
through acetylation and methylation.
Epigenetic modifications act to control the accessibility of
DNA to transcription. Methylation of cytosines in regulatory
elements or the complexing of DNA around nucleosomes can
block gene expression, while removal of DNA methylation or
relaxing of histone complexing can make DNA more
accessible. Methylation often acts on CpG islands or shores,
whichareregionsofcytosine–guaninedinucleotidesequences
in promoters of genes, thus inhibiting the binding of
transcription factors. One or both strands may be methylated,
which can fine-tune the degree of expression. In addition,
methylation of these regions can recruit histone modifications
that also block transcription machinery. In contrast, methyl-
ationwithinthegeneexonsandintronsiscorrelatedwithgene
expression. DNA methylation is mediated by a family of
DNMT enzymes which apply and maintain methylation tags
(Day and Sweatt 2011; Portela and Esteller 2010;G r o p m a n
and Batshaw 2010).
Histone modification affects the wrapping of DNA
around nucleosomes, which are octomers composed of
two each of four different histone proteins: H2A, H2B, H3,
H4. DNA complexing with nucleosomes is part of
chromatin compaction into heterochromatin, which gener-
ally is less transcriptionally active. Each histone protein has
multiple sites that are subject to modification (methylation,
acetylation, phosphorylation, ubiquination, ADP ribosyla-
tion, or sumoylation) (Kouzarides 2007). Specific sites are
designated by the histone type and the amino acid number,
such that H4K12 designates the 14th amino acid in an H4
protein, which is a lysine (K). These modifications are
reversible, mediated by families of enzymes such as histone
acetylases (HATs), histone deacetylases (HDACs), histone
methylases (HMTs), histone demethylases (HDMs), and so
on. The combination of histone modifications at different
histone sites appears to constitute a “code” or “language”
that determines when, where, and how much a particular
gene is expressed (Day and Sweatt 2011; Portela and
Esteller 2010; Lee et al. 2010).
Mutations of genes affecting epigenetic mechanisms
in humans and animal models
Since epigenetic mechanisms regulate the differential expres-
sion of genes in developing tissues, gene mutations that
interfere with DNA methylation or histone modification may
disrupt multiple organ systems. Table 1 gives several
examples of developmental cognitive disorders caused by
mutations in genes that disrupt epigenetic processes resulting
in varying degrees of motor, craniofacial, and skeletal
problems in addition to their effects on cognitive abilities.
Other cognitive disorders such as Alzheimer Disease and
Huntington Disease develop in adulthood through gradual
neurodegeneration secondary to deregulated genes.
While the effects of mutations of genes that affect
epigenetic processes can be severe and disrupt multiple
systems, other genetic effects on epigenetic modification
can be much more circumscribed. The “language” of
methylated DNA and specific histone modifications can
precisely control gene expression to produce and maintain
tissue-specific and region-specific cellular differentiation.
Once differentiation is completed, the same regulatory
mechanisms appear to be involved in the changes in gene
expression that result from learning and memory in the
hippocampus (Day and Sweatt 2011). For example, certain
types of learning are correlated with specific patterns of
histone modification in chromatin of hippocampal cells, e.g.,
the learning of contextual fear responses in mice is associated
withacetylationatH3K9,H3K14,H4K5,H4K8,andH4K12,
as well as changes in methylation and phosphorylation at
other sites. Moreover, loss of acetylation at H4K12 interferes
with learning, which is normalized by introduction of an
HDACinhibitorwhichrestoresactylationatthatsite(Dayand
Sweatt 2011; Peleg et al. 2010). Similarly, interference with
the machinery that applies histone modifications or DNA
methylation such as HATs, HDACs, HDMs, or DNMTs also
cause learning problems; for example, mutation of the Cbp
gene in mice, or blockage of DNA methylation through
inhibition of Dnmts will both interfere with memory and
long-term potentiation in the hippocampus (Day and Sweatt
2011; Alarcon et al. 2004; Lubin et al. 2008; Levenson et al.
2006; Miller and Sweatt 2007). The EHMT gene in humans
encodes a histone demethylase and heterozygous deletion of
this telomeric gene causes Kleefstra syndrome, a condition
with severe intellectual disability, dysmorphic features, and
behavioral problems such as autistic features, aggression,
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severity over time (Kleefstra et al. 2009). In Drosophila,
mutation of the EHMT homologue results in disruption of a
jumping reflex and courtship memory. These deficits were
also rescued by expression of EHMT in adult flies (Kramer
et al. 2011). Additional studies of mouse models of
Alzheimer disease and other neurodegenerative diseases
have also shown rescue of learning deficits with treatment
by HDACs (Fischer et al. 2007;G u a ne ta l .2009).
Mostrecently,therehavebeenseveralreportsofalterations
of methylation in autism spectrum disorders. Alterations in
methylation of CpG islands associated with the OXTR
oxytocin receptor gene have been reported in brain tissues
of individuals with autism spectrum disorders (Gregory et al.
2009). Abstracts at the International Congress of Human
Genetics/American Society of Human Genetics meeting
in Montreal in October 2011 reported that identical
twins discordant for autism had significantly different
genome-wide methylation patterns (Wong et al. 2011),
and siblings discordant for autism had differences in 5-
hydroxymethylcytosine across exonic sequences. Finally,
DNA methylation was altered in CpG islands associated with
the candidate gene SHANK3 in brain samples from individuals
with autism spectrum disorders, resulting in an altered pattern
of isoform expression (Zhu et al. 2011). The influence of more
remote regulatory regions was noted in the downregulation of
the CHRNA7 gene in autism by the Prader Willi imprinting
center at 15q11.2–13.3 (Yasui et al. 2011).
Mouse models of human epigenetic syndromes, such as
those listed in Table 1, can show severe phenotypic effects
similar to their human counterparts (unless the models are
constructed such that the mutations are only expressed in
selected tissues); however, many of these disorders are
caused by null mutations that have a significant effect on
function. Other models of mutations of genes affecting
epigenetic regulation can show much milder changes in
hippocampal neurons or dendritic spines (Lagali et al.
2010). It seems possible, then, that less disruptive mutations
or mutations of other genes may have much more focused
effects on development and thus may be much more
analogous to deficits that affect reading and language
disorders. Thus, while mutations affecting epigenetic mech-
anisms have not been described in reading disability or
language impairments, the role of epigenetic changes in
learning and autism and the hints of potential therapy make it
especially worthwhile to look for mutations in such genes in
individuals with language and learning problems.
Approaches to the identification of epigenetic mechanisms
in humans
Although candidate genes have been identified for reading
disability and language impairment, the SNPs in these
genes appear to account for a small portion of the
phenotypic variability. In contrast, fairly substantial herit-
abilities have been claimed for these disorders, between
Table 1 Developmental disorders resulting from disruption of epigenetic mechanisms (Galaburda 2005)
Mechanism Disease Gene Effect Consequences
DNA methylation Rett syndrome MeCP2 Hypermethylation, abnormal
mRNA splicing
Transcription repression
or activation
Fragile X syndrome FMR1 Promoter hypermethylation Transcription repression
Prader Willi syndrome/
Angelman syndrome
del15q11-q13, UBE3A Aberrant methylation in
imprint control region
Transcription repression
or activation
Immunodeficiency,
centromere instability,
facial dysmorphism
DNMT3B Hypomethylation Transcription activation
Alzheimer disease NEP CpG island hypomethylation Transcription activation
Histone acetylation Rubenstein-Taybi
syndrome
CBP (HAT) Reduced histone acetylation,
hypertrimethylation of DNA
Transcription repression
Coffin-Lowry syndrome RSK32 Hypophosphorylation of site
H3S10
Increased transcription
of MAP kinase genes
Oculofaciocardio-dental BCOR Disruption of HDACs Transcription activation
Histone methylation Sotos syndrome NSD1 Decreased methylation of sites
H4K20, H3K36
Transcription activation
of multiple genes
Kleefstra syndrome EHMT1 Decreased histone methylation Transcription activation
Huntington Disease HTT Increased methylation at site
H3K9 and possibly H3K27
Transcription activation
Galaburda (2005) adapted from Portela and Esteller (2010); Day and Sweatt (2011); Kelly et al. (2010), Lagali et al. (2010); and Gropman and
Batshaw (2010)
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and Olson 2001; Hawke et al. 2006; Astrom et al. 2007;
Spinath et al. 2004; Tomblin and Buckwalter 1998; Dale et
al. 1998; Bishop and Hayiou-Thomas 2008). There are
several possible explanations for this “missing heritability,”
but one of the primary reasons appears to be inherent in the
current studies of SNPs, particularly in the large panels that
are used for genome-wide studies. The SNPs selected for
such panels are generally common in the population, which
makes them more informative in comparisons between
affected and unaffected individuals, but assessment of
individual common SNPs ignores rare variants which are
likely to have more impact, and also ignores epistatic
interactions between loci (Manolio et al. 2009). There are
approaches that enhance the identification of causal genes
from genome-wide association studies (GWAS) data such
as the simultaneous analysis of multiple variants associated
with a gene (Neale and Sham 2004; Huang et al. 2011;L ie t
al. 2011) or focus on SNPs associated with loci which show
phenotype-based differences in expression (eQTLs or
eSNPs) (Innocenti et al. 2011; Majewski and Pastinen
2011) and “next generation sequencing” allows the analysis
of rare as well as common variants around a gene; however,
sites involved in epigenetic control of gene expression may
not be included in the set of loci in gene-based analysis, and
the variation in expression of eQTLs may be due in part to
mutations in epigenetic regions which may be somewhat
distant from the gene itself (Ernst et al. 2011). The
influence of remote regulatory elements is likely to be
missing in targeted screening approaches which focus on
candidate genes, whether through SNP analysis or sequenc-
ing. This is due in part to the lack of information on where
these regions are located, and initiatives such as the NIH
Epigenomics Roadmap Program (http://nihroadmap.nih.gov/
epigenomics/initiatives.asp) and the International Human
Epigenome Consortium (http://www.ihec-epigenomes.org/).
These are large collaborative efforts to map regions in the
genome that are involved in epigenetic regulation, and the
results will assist investigators in identifying regions for
evaluation.
Heritable mutations that influence reading and language
disorders could be in the genes that regulate epigenetic
processes, analogous to the mutations in HDACs or
DNMTs, or in genes such as MeCP2 or in the MAPK
signaling pathway (Day and Sweatt 2011). Alternatively,
mutations could be in the DNA binding regions themselves.
Genome-wide association studies or even targeted SNP
analysis might be able to detect such mutations, given that
the sample size is large enough, the variants are not rare,
and the adjacent SNPs are in linkage disequilibrium.
Knowledge of the location of epigenetic regions could help
prioritize the follow-up of SNPs in a GWAS that otherwise
might be ignored because of lack of apparent functional
relevance (Ernst et al. 2011), and location information
would also guide the placement of SNPs in a targeted array.
Sequence analysis would detect rare variants, but until
whole genome sequencing of large populations is finan-
cially feasible, targeted sequencing studies are also depen-
dent upon the selection of candidate genes and regulatory
regions. Studies of epigenetic mechanisms in animal
models should produce additional candidate genes for
examination in cognitive disorders in humans.
Another approach would be to look for genomic regions of
abnormal methylation or histone modification in individuals
with specific forms of language or learning disorders.
However, epigenetic patterns are likely to be different in
different tissues, and histone modifications especially may
changeovertime.Fortunately,therearestudieswhichindicate
that methylation patterns affecting disorders can be consistent
across tissues, such as lymphocyte and brain methylation
patterns in individuals with psychiatric disorders, suggesting
that lymphocyte tissues can be a good proxy for brain
(Dempster et al. 2011). An abnormal methylation pattern in
a region of DNA from human tissues such as lymphocytes or
fibroblasts could indicate an epigenetic process that could be
pursued further by determination of the effects of that
abnormality on gene expression and the impact on learning
in animal models. Such studies could be valuable in
identifying important genes and signaling pathways involved
in learning. Further genetic studies such as association and
sequencing could assess the influence of these new candi-
dates at the population level. Conversely, though, lack of a
methylation abnormality in “proxy” tissues would not rule
out the involvement of an epigenetic mechanism that is
confined to a region of the brain.
There are many approaches to the identification of genes
that affect quantitative traits such as language and learning
disorders, and the most effective will take advantage of
simultaneous analysis of genomic and expression analyses
(Charlesworth et al. 2009). The inclusion of information on
epigenetic mechanisms of gene regulation may turn out to
be an important consideration in gene identification and
possibly even in therapy.
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